- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
The Mainstream Patient: August 17
This week’s edition of The Mainstream Patient features stories about hair loss and COVID-19, natural deodorant rashes, cortisone shots for acne, CVS removing octinoxate and oxybenzone from its store-brand sunscreens, plus more.
Introducing The Mainstream Patient, a weekly glimpse into what your patients may be reading in the media about skin health.
In this week’s edition, Allure reveals how to properly remove skin tags and gives an update on CVS removing octinoxate and oxybenzone from its store-brand sunscreens. Meanwhile, Self dives into cortisone shots for acne and rashes that result from natural deodorant use. Glamour explains retinol and how it can be used for treatment of both wrinkles and acne. Finally, Shape writes about hair loss associated with COVID-19.
What You Need to Know About COVID-19 and Hair Loss
What Is Retinol and How Do You Use It?
Here’s Why Your Natural Deodorant Gave You a Rash
What You Need to Know Before Getting a Cortisone Shot for Acne
How to Remove Skin Tags, According to Dermatologists
CVS Is Eliminating Oxybenzone and Octinoxate From Nearly 60 of Its Store-Brand Sunscreens
